VENTYX BIOSCIENCES INC's ticker is and the CUSIP is 92332V107. A total of 144 filers reported holding VENTYX BIOSCIENCES INC in Q3 2023. The put-call ratio across all filers is 0.72 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $32,295,427 | +4.7% | 929,900 | -1.1% | 1.54% | +29.8% |
Q2 2023 | $30,848,170 | +12.9% | 940,493 | +15.3% | 1.18% | -0.2% |
Q1 2023 | $27,328,429 | -6.9% | 815,774 | -8.8% | 1.19% | -1.2% |
Q4 2022 | $29,346,197 | -38.4% | 894,974 | -34.4% | 1.20% | -35.1% |
Q3 2022 | $47,652,000 | – | 1,365,000 | – | 1.85% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
venBio Partners LLC | 2,298,833 | $77,010,906 | 42.68% |
Qiming U.S. Ventures Management, LLC | 746,370 | $25,003,395 | 30.26% |
TCG Crossover Management, LLC | 815,724 | $27,326,754 | 5.33% |
ACUTA CAPITAL PARTNERS, LLC | 208,500 | $6,984,750 | 5.15% |
Affinity Asset Advisors, LLC | 260,008 | $8,710,268 | 2.88% |
Avidity Partners Management LP | 1,917,800 | $64,246,300 | 2.13% |
Integral Health Asset Management, LLC | 290,000 | $9,715,000 | 1.96% |
Tri Locum Partners LP | 152,842 | $5,120,207 | 1.56% |
Vivo Capital, LLC | 602,075 | $20,169,513 | 1.40% |
Boxer Capital, LLC | 850,000 | $28,475 | 1.40% |